PATIENT-REPORTED ASSESSMENT TOOL DEDICATED FOR ASSESSMENT OF OXALIPLATIN-INDUCED PERIPHERAL NEUROPATHY (OIPN)

PATIENT-REPORTED ASSESSMENT TOOL DEDICATED FOR ASSESSMENT OF OXALIPLATIN-INDUCED PERIPHERAL NEUROPATHY (OIPN)

The present invention discloses a patient-reported assessment tool dedicated for assessment of oxaliplatin-induced peripheral neuropathy (OIPN), comprising a main scale, a subscale and a scoring formula. The assessment contents of the main scale contain symptoms of body organs and are graded based o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: GU, Zhancheng, HUO, Jiege, WEI, Guoli
Format: Patent
Sprache:eng
Schlagworte:
HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA
INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS
PHYSICS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator GU, Zhancheng
HUO, Jiege
WEI, Guoli
description The present invention discloses a patient-reported assessment tool dedicated for assessment of oxaliplatin-induced peripheral neuropathy (OIPN), comprising a main scale, a subscale and a scoring formula. The assessment contents of the main scale contain symptoms of body organs and are graded based on patient's subjective feelings about the frequency of the neuropathy, corresponding to relative scores. The assessment contents of the subscale contain location, duration and influence of the most severe symptom. The present invention effectively improves the accuracy and sensitivity of CIPN assessment through the targeted application range design and the maximum item weight addition, and improves the clinical reference value of CIPN assessment by elaborating the description of OIPN symptoms and integrating the features of several validated assessment tools, and provides reference for the development of CIPN assessment tools.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2024136030A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2024136030A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2024136030A13</originalsourceid><addsrcrecordid>eNqNjb0KwjAYRbM4iPoOARcdCm1T3EPylQRivpAf0KkUiZM_hfr-GMHB0enCPYd7l-TueNRgY-XBoY8gKQ8BQjiWjkZEQyVILfiH9Oh_KfYUT9xoZ8qErbSVSRTLgddOgeeGWkgey4E60x1qZ_drsriOtzlvvrki2x6iUFWenkOep_GSH_k1pNDWbdewQ81q3rD_rDdWoThG</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PATIENT-REPORTED ASSESSMENT TOOL DEDICATED FOR ASSESSMENT OF OXALIPLATIN-INDUCED PERIPHERAL NEUROPATHY (OIPN)</title><source>esp@cenet</source><creator>GU, Zhancheng ; HUO, Jiege ; WEI, Guoli</creator><creatorcontrib>GU, Zhancheng ; HUO, Jiege ; WEI, Guoli</creatorcontrib><description>The present invention discloses a patient-reported assessment tool dedicated for assessment of oxaliplatin-induced peripheral neuropathy (OIPN), comprising a main scale, a subscale and a scoring formula. The assessment contents of the main scale contain symptoms of body organs and are graded based on patient's subjective feelings about the frequency of the neuropathy, corresponding to relative scores. The assessment contents of the subscale contain location, duration and influence of the most severe symptom. The present invention effectively improves the accuracy and sensitivity of CIPN assessment through the targeted application range design and the maximum item weight addition, and improves the clinical reference value of CIPN assessment by elaborating the description of OIPN symptoms and integrating the features of several validated assessment tools, and provides reference for the development of CIPN assessment tools.</description><language>eng</language><subject>HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA ; INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS ; PHYSICS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240425&amp;DB=EPODOC&amp;CC=US&amp;NR=2024136030A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240425&amp;DB=EPODOC&amp;CC=US&amp;NR=2024136030A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GU, Zhancheng</creatorcontrib><creatorcontrib>HUO, Jiege</creatorcontrib><creatorcontrib>WEI, Guoli</creatorcontrib><title>PATIENT-REPORTED ASSESSMENT TOOL DEDICATED FOR ASSESSMENT OF OXALIPLATIN-INDUCED PERIPHERAL NEUROPATHY (OIPN)</title><description>The present invention discloses a patient-reported assessment tool dedicated for assessment of oxaliplatin-induced peripheral neuropathy (OIPN), comprising a main scale, a subscale and a scoring formula. The assessment contents of the main scale contain symptoms of body organs and are graded based on patient's subjective feelings about the frequency of the neuropathy, corresponding to relative scores. The assessment contents of the subscale contain location, duration and influence of the most severe symptom. The present invention effectively improves the accuracy and sensitivity of CIPN assessment through the targeted application range design and the maximum item weight addition, and improves the clinical reference value of CIPN assessment by elaborating the description of OIPN symptoms and integrating the features of several validated assessment tools, and provides reference for the development of CIPN assessment tools.</description><subject>HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA</subject><subject>INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS</subject><subject>PHYSICS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjb0KwjAYRbM4iPoOARcdCm1T3EPylQRivpAf0KkUiZM_hfr-GMHB0enCPYd7l-TueNRgY-XBoY8gKQ8BQjiWjkZEQyVILfiH9Oh_KfYUT9xoZ8qErbSVSRTLgddOgeeGWkgey4E60x1qZ_drsriOtzlvvrki2x6iUFWenkOep_GSH_k1pNDWbdewQ81q3rD_rDdWoThG</recordid><startdate>20240425</startdate><enddate>20240425</enddate><creator>GU, Zhancheng</creator><creator>HUO, Jiege</creator><creator>WEI, Guoli</creator><scope>EVB</scope></search><sort><creationdate>20240425</creationdate><title>PATIENT-REPORTED ASSESSMENT TOOL DEDICATED FOR ASSESSMENT OF OXALIPLATIN-INDUCED PERIPHERAL NEUROPATHY (OIPN)</title><author>GU, Zhancheng ; HUO, Jiege ; WEI, Guoli</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2024136030A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2024</creationdate><topic>HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA</topic><topic>INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS</topic><topic>PHYSICS</topic><toplevel>online_resources</toplevel><creatorcontrib>GU, Zhancheng</creatorcontrib><creatorcontrib>HUO, Jiege</creatorcontrib><creatorcontrib>WEI, Guoli</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GU, Zhancheng</au><au>HUO, Jiege</au><au>WEI, Guoli</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PATIENT-REPORTED ASSESSMENT TOOL DEDICATED FOR ASSESSMENT OF OXALIPLATIN-INDUCED PERIPHERAL NEUROPATHY (OIPN)</title><date>2024-04-25</date><risdate>2024</risdate><abstract>The present invention discloses a patient-reported assessment tool dedicated for assessment of oxaliplatin-induced peripheral neuropathy (OIPN), comprising a main scale, a subscale and a scoring formula. The assessment contents of the main scale contain symptoms of body organs and are graded based on patient's subjective feelings about the frequency of the neuropathy, corresponding to relative scores. The assessment contents of the subscale contain location, duration and influence of the most severe symptom. The present invention effectively improves the accuracy and sensitivity of CIPN assessment through the targeted application range design and the maximum item weight addition, and improves the clinical reference value of CIPN assessment by elaborating the description of OIPN symptoms and integrating the features of several validated assessment tools, and provides reference for the development of CIPN assessment tools.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US2024136030A1
source esp@cenet
subjects HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATIONTECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING ORPROCESSING OF MEDICAL OR HEALTHCARE DATA
INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTEDFOR SPECIFIC APPLICATION FIELDS
PHYSICS
title PATIENT-REPORTED ASSESSMENT TOOL DEDICATED FOR ASSESSMENT OF OXALIPLATIN-INDUCED PERIPHERAL NEUROPATHY (OIPN)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T22%3A02%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GU,%20Zhancheng&rft.date=2024-04-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2024136030A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true